BackSumitomo Pharma , Ltd. Overview

Sumitomo Pharma , Ltd. Total Liabilities

Latest total liabilities for SMDPY: $420B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$419.95B
↓ 19.40% YoYΔ $-101.06B vs prior year quarter

Peer trimmed avg / median

Loading

Sumitomo Pharma , Ltd. Total Liabilities History

Loading

Sumitomo Pharma , Ltd. vs. peers: Total Liabilities Comparison

Loading

Sumitomo Pharma , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

As of the most recent data (September 2026), SMDPY shows a total liabilities of $420B. That compares with $520B in the prior-year period — down 19.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SMDPY's total liabilities is now $420B (was $520B) — a 19.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sumitomo Pharma , Ltd. is outperforming or lagging.

Tracking SMDPY's total liabilities over time shows whether Sumitomo Pharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $420B That compares with $520B in the prior-year period — down 19.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Sumitomo Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $420B) with ownership activity and broader fundamentals.